Passionate about making a profound impact on peoples’ lives

Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral diseases. We have multiple ongoing clinical programs focused on the development of novel antivirals to treat herpesviruses, hepatitis delta virus (HDV) and hepatitis B virus (HBV). Further, our research organization is dedicated to the discovery of new therapies to change the treatment paradigm for viral infections.

Advancing the treatment paradigm for serious viral diseases

Assembly Bio’s team is focused on advancing treatment options for people through the discovery and development of novel antivirals. We are leveraging our extensive expertise in virology to deliver breakthrough therapeutics with the potential to improve outcomes for individuals struggling with the impacts of serious viral diseases.

Explore programs


Board of Directors

William Ringo

Chairman of the Board, Non-Executive

orange arrow
Anthony Altig

Director

orange arrow
Tomas Cihlar, PhD

Director

orange arrow
Gina Consylman

Director

orange arrow
Rob Cook

Director

orange arrow
Sir Michael Houghton, PhD

Director

orange arrow
Lisa Johnson-Pratt, MD

Director

orange arrow
Sue Mahony, PhD

Director

orange arrow
John McHutchison AO, MD

Director

orange arrow
Jason Okazaki

Chief Executive Officer & President, Director

orange arrow

Contact Us

CORPORATE HEADQUARTERS
Two Tower Place
7th floor
South San Francisco, CA 94080
Get Directions

FOR GENERAL INFORMATION,
PLEASE CONTACT:

833.509.4583
info@assemblybio.com

FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:

BD@assemblybio.com